Skip to main content
. 2018 Mar 8;9(20):15208–15218. doi: 10.18632/oncotarget.24622

Table 1. RPN2 expression and clinicopathological factors.

Factors RPN2 expression P-value
positive 19 negative 21
Age 70≧ 4 7 P = 0.488
70< 15 14
Sex male 14 17 P = 0.583
female 5 4
cT T3(SS) 3 4 P = 0.557
T4a(SE) 15 17
T4b(SI) 1 0
cN N0 2 1 P = 0.897
N1 6 6
N2 7 9
N3 4 5
cM absent 14 12 P = 0.333
present 5 9
cStage IIB 3 0 P = 0.392
IIIA 5 5
IIIB 5 4
IIIC 1 3
IV 5 9
Macroscopic Type 2 5 9 P = 0549
type Type 3 7 6
Type 4 7 6
Histological differentiated 2 9 P = 0.034
type undifferentiated 17 12
Treatment after DCS gastrectomy 15 16 P = 0.749
Continue DCS, and subsequent gastrectomy 4 5

Abbreviations: DCS = docetaxel combined with S-1 and cisplatin; RPN2 = ribophorin II. Analyzed by Fisher's exact test.